Hospital San Pedro

The trials here

What the 36 trials at this site are about, from their registry records.

Conditions

• Lung cancer7 trials
• Multiple myeloma3 trials
• Obesity3 trials
• Obstructive sleep apnoea3 trials
• Bladder cancer2 trials
• Bronchiectasis2 trials
• Endometrial cancer2 trials
• Familial hypercholesterolaemia2 trials
• HIV2 trials
• Metastatic breast cancer2 trials
• Multiple sclerosis2 trials
• Ovarian cancer2 trials
• and 20 more

Phase

• Phase 311 trials
• Phase 1/28 trials
• Phase 25 trials
• Phase 42 trials
• Phase 11 trial

Status

• Recruiting19 trials
• Active, not recruiting8 trials
• Not yet recruiting6 trials
• Completed3 trials

Lead sponsor

• PETHEMA Foundation3 trials
• Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2 trials
• Eli Lilly and Company2 trials
• GlaxoSmithKline2 trials
• Novo Nordisk A/S2 trials
• and 24 more

Running trials

• Not yet recruiting

  Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual Treatment

  NCT07921667· International University of La Rioja· Source

  Contact: Sara Barbeito Resa, PhD

• Recruiting

  A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC)

  NCT07465757· Phase 2· Puma Biotechnology, Inc.· Source

• Recruiting

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

  NCT07659782· Phase 2· Verastem, Inc.· Source

• Not yet recruiting

  Phase Ib/II Study of Zanidatamab Plus Tucatinib and Chemotherapy in HER2-Positive Advanced Breast Cancer

  NCT07494448· Phase 1/2· MedSIR· Source

• Recruiting

  AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  NCT07571005· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  NCT07571109· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis

  2025-521546-23-00· Phase 3· Novartis Pharma AG· Source

• Recruiting

  A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

  NCT07456033· Phase 3· GlaxoSmithKline· Source

• Recruiting

  A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC

  NCT07491497· Phase 1/2· TRIANA Biomedicines, Inc.· Source

• Not yet recruiting

  Treatment for Ph-negative ALL for Adults up to 65 Years

  NCT07443592· PETHEMA Foundation· Source

  Contact: Andrea Campeny, Dr (principal investigator)

• Recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  NCT07369011· Phase 3· Eli Lilly and Company· Source

  Contact: Alejandra Roncero Lázaro (principal investigator)

• Recruiting

  A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

  NCT07244341· Phase 1· Daiichi Sankyo· Source

• Recruiting

  A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

  NCT07186842· Phase 1/2· BioNTech SE· Source

• Active, not recruiting

  A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

  NCT07170150· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

  NCT07201051· Phase 2· GlaxoSmithKline· Source

• Recruiting

  A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

  NCT07174583· Phase 1/2· IDEAYA Biosciences· Source

• Recruiting

  Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)

  NCT07048262· Phase 2· CSL Behring· Source

• Not yet recruiting

  Exploring the Anti-ageing Effects of Metformin in COPD

  NCT06999343· Phase 3· Fundación Instituto de Investigación Sanitaria de Navarra· Source

• Active, not recruiting

  A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT06686615· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source

• Recruiting

  Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs

  NCT06567015· Phase 1/2· Pierre Fabre Medicament· Source

• Recruiting

  First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations

  NCT06043817· Phase 1/2· Pierre Fabre Medicament· Source

• Active, not recruiting

  A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV

  NCT06518408· University Hospital Virgen de las Nieves· Source

• Recruiting

  First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  NCT05768139· Phase 1/2· Eli Lilly and Company· Source

• Recruiting

  NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide

  NCT05558319· Phase 3· PETHEMA Foundation· Source

  Contact: María José Nájera Irazu, Dr

• Active, not recruiting

  Extended VRD plus Early Rescue vs Isatuximab-VRD vs Isatuximab-VIberdomide-D for NDMM patients who are candidates for ASCT

  2024-517008-12-00· Phase 3· Fundacion PETHEMA· Source

• Recruiting

  Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

  NCT05098132· Phase 1/2· Synthekine· Source

• Recruiting

  Study to evaluate the efficacy and safety of supportive mitomycin C administered via electric current in the treatment of non-muscle invasive bladder cancer versus the standard immunotherapy.

  2024-520006-19-00· Phase 4· Presurgy S.L.· Source

• Active, not recruiting

  Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

  NCT05156281· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT04579367· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source

• Recruiting

  Spanish Registry of Esophagogastric Cancer

  NCT04958720· Fundación Sociedad Española de Oncologia Médica· Source

  Contact: Paula Dr Jiménez Fonseca, MD-PhD

• Enrolling by invitation

  A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)

  NCT04093570· Phase 2· Taiho Oncology, Inc.· Source

• Active, not recruiting

  Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years

  NCT03742297· Phase 3· PETHEMA Foundation· Source

• Active, not recruiting

  Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain

  NCT03605771· Grupo Español Multidisciplinar de Melanoma· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer7 recruiting
• Obesity3 recruiting
• Obstructive sleep apnoea3 recruiting
• Bladder cancer2 recruiting
• Bronchiectasis2 recruiting
• Endometrial cancer2 recruiting
• Metastatic breast cancer2 recruiting
• Ovarian cancer2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukaemia1 recruiting
• Asthma1 recruiting
• Bipolar disorder1 recruiting
• Cervical cancer1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Colorectal cancer1 recruiting
• COPD1 recruiting
• Cystic fibrosis1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Head and neck cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Multiple myeloma1 recruiting
• Multiple sclerosis1 recruiting
• Myelodysplastic syndromes1 recruiting
• Neuroendocrine tumours1 recruiting
• Pancreatic cancer1 recruiting
• Prostate cancer1 recruiting
• Schizophrenia1 recruiting

Closed trials

• Completed

  Potential Use of a POCT for the Direct Transfer of Stroke Patients From the Ambulance to the Thrombectomy Center

  NCT05833945· Fundación Pública Andaluza para la gestión de la Investigación en Sevilla· Source

• Completed

  Safety Evaluation of Edoxaban in Elderly Patients With Frailty Criteria

  NCT05732506· Galaxia Empírica· Source

• Completed

  A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection

  NCT04076423· Phase 4· Fundacion SEIMC-GESIDA· Source